Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (-) -carvone, geraniol and a further essential oil component

Details for Australian Patent Application No. 2011231511 (hide)

Owner Cesa Alliance S.A.

Inventors Coppens, Christine

Agent Dennemeyer & Associates

Pub. Number AU-A-2011231511

PCT Pub. Number WO2011/117424

Priority 10157930.8 26.03.10 EP

Filing date 28 March 2011

Wipo publication date 29 September 2011

International Classifications

A61K 31/045 - Hydroxy compounds, e.g. alcohols

A61K 31/122 - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/16 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/20 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/22 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

18 October 2012 PCT application entered the National Phase

  PCT publication WO2011/117424 Priority application(s): WO2011/117424

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011231513-Method for determining the density of a multiphase fluid, densitometer using said method and multiphase meter using said densitometer

2011231508-Tricyclic indole derivatives as PBR ligands